Navigation Links
BELLUS Health announces closing of Innodia acquisition
Date:7/17/2008

Company announces change to senior management team

--------------------------------------------------

LAVAL, QC, July 17 /PRNewswire-FirstCall/ - BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU, formerly known as Neurochem Inc.) announced today the closing of the acquisition of Innodia Inc. that it had previously announced on July 16, 2008.

As a result of this acquisition, BELLUS Health is also announcing a change at the management level in the field of research. Nigel Levens, Ph.D., Chief Scientific Officer of Innodia Inc. will take on the position of Vice President, Research at BELLUS Health while Daniel Delorme, Ph.D., BELLUS Health's current Vice President, Research, will be leaving the Company to pursue other interests.

"I am very pleased to welcome Dr. Levens to the Company," said Dr. Francesco Bellini, Chairman, President and CEO of BELLUS Health. "The expertise he demonstrated in drug discovery for metabolic diseases at Innodia, will serve us very well at BELLUS Health. I also want to thank Dr. Delorme for his valuable contribution to the Company during his tenure with us and wish him great success in his future endeavours."

Dr. Levens brings to the position 27 years of teaching and research in the field of metabolic and cardiovascular diseases in both Europe and North America. Prior to joining Innodia in 2006, he worked as Head of Biology for Biovitrum AB of Sweden, which specializes in metabolic diseases such as Type II diabetes, obesity, and metabolic syndrome. From 1998-2003, he served as Head of the Division of Metabolic Diseases for the Servier Research Group in France and prior to that as Head of Obesity Pharmacology for Novartis Pharma in Basel, Switzerland. Educated in both the United Kingdom and the United States, Dr. Levens holds a B.Sc. (Hons.) in Physiology and Biochemistry, and a Ph.D. in Physiology from the University of Southampton in the United Kingdom and conducted a postdoctoral fellows
'/>"/>

SOURCE BELLUS HEALTH INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
2. BELLUS HEALTH reports results for first quarter of fiscal 2008
3. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
4. Penn study finds pro-death proteins required to regulate healthy immune function
5. UCLA researchers identify markers that may predict diabetes in still-healthy people
6. Air pollution linked to cardiovascular risk indices in healthy young adults
7. More proof needed of safety and quality of electronic personal health records
8. Health care incentive model offers collaborative approach
9. Loneliness is bad for your health
10. Mailman School of Public Health study examines link between racial discrimination and substance use
11. Green Tea May Brew Up Healthier Skin

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... InhibOx, a leading developer of novel and effecti...oined forces with MolPort, an innovator in rare ch... chemical trading platform and builds database of ...his database and its updates to computational chem... virtual screening procedures. Once they identify ...
(Date:12/4/2009)...Plantar fasciitis heel pain affects over two milli... therapy has been cited by the American Academy of...ion. In response to these findings, Orthotics And... therapy systems for plantar fasciitis treatment a...lint therapies. , (PRWEB)...
(Date:12/4/2009)...f., Dec. 4 Herpes zoster, also kno...ve been vaccinated against chicken pox, according ... of the Pediatric Infectious Diseases Journal. ,...tronic health records to identify more than 170,00...pox) vaccine from 2002 to 2008 in Kaiser Permanent...
(Date:12/3/2009)...With a membership increase of more than 15 percent...ly as a milestone in its history, but also as a si...ociations are experiencing a decline in membership...when trade organizations across the nation are suf... unprecedented growth, signaling that physicians s...
(Date:12/3/2009)....J., Dec. 3 The development of Uni...(UMCPP) reached a milestone today with a "topping ...me construction at the new hospital that will repl... ,, (Photo: http://www.newscom.com/cgi-bin/prn...is a steelworkers, tradition in which a steel beam...
Breaking Medicine News(10 mins):Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 2Health News:InhibOx and Molport Join Forces to Deliver Integrated Lead Design and Delivery 3Health News:Orthotics And Beyond Introduces Compressive Cold Therapy Products for Plantar Fasciitis Treatment 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 2Health News:Chicken Pox Vaccine May Also Reduce Risk of Shingles Among Children 3Health News:Florida Medical Association Marks Record Membership Growth 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 2Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 3Health News:'Topping Out' Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro 4
(Date:12/3/2009)...NEW YORK, Dec. 3 Guidepoint Globa...nounced the launch of their Sleep Apnea Tracker, a...nd projects trends and market share in the worldwi...ker captures actual patient usage for 87 different... from 15 different equipment providers going back ...
(Date:12/3/2009)..., DOYLESTOWN, Pa., Dec. 3 /PRNewswire-FirstCall/...rporation, (Nasdaq: QGLY ) www.quigleyco.com an...valuation of its opportunities to develop prescrip...uded that it is in its best interests to focus pri... may include but are not limited to its Cold-EEZE&...
(Date:12/3/2009)..., FORT WORTH, Texas, Dec. 3 /PRNewswire-First...C Bulletin Board: WNDM), a rapidly growing provide...n agreement with the Health Industry Representativ...ndependent sales and marketing representative to m...ct within the U.S. ,, HIRA will market and sel...
Breaking Medicine Technology:Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 1Cooper Martin Unveils Innovative Stylish Recovery Clothing for Those with Limited Mobility 48188 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 1Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 2Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association 4562 3Researchers work to boost effectiveness of the flu vaccine 48184 1Researchers work to boost effectiveness of the flu vaccine 48184 2Researchers work to boost effectiveness of the flu vaccine 48184 3
...rnal of Clinical Lipidology publishes largest stud.../simvastatin to statin therapies using FDA databas...creased cancer risk with ezetimibe mono and ezetim...o cancer rates of other powerful lipid-lowering st...ical Center lipid and health policy experts, was p...
...ERUSALEM, March 25 Oramed Pharmaceuticals,Inc. (O...per of oral delivery,systems, announced today that...the study, entitled, "Open Label Study to Assess t...cs (PD) of Oral Insulin Formulations,in Subjects w...nnual American,Diabetes Association,s Scientific S...
Other Medicine Technology:Ezetimibe and Ezetimibe/Simvastatin Combo Pose No Increased Cancer Risk, Study Shows 2Oramed Pharmaceuticals to Present Oral Insulin Phase 2A Trial Results at the Upcoming Annual Meeting of the ADA (June 5-9, New Orleans, LA) 2
Optima III Noninsulated Allis Tooth Grasper, without ratchet
Optima III Noninsulated Duck-Bill Grasper, with ratchet
Uninsulated locking handle
Snap-In Snap-Out®-II Single Ring Handle, ratcheted, noninsulated handle, insulated shaft
Medicine Products: